# Clinical Trial on Ganoderma Spore Lipids Combined With Chemo in Patients With G.I. Cancers

> **NCT02785523** · PHASE3 · UNKNOWN · sponsor: **Xiaonan Cui** · enrollment: 60 (estimated)

## Conditions studied

- Gastrointestinal Neoplasms

## Interventions

- **DRUG:** Ganoderma Spore Lipids
- **DRUG:** Placebo
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT02785523
- **Lead sponsor:** Xiaonan Cui
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2017-05
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2016-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02785523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02785523, "Clinical Trial on Ganoderma Spore Lipids Combined With Chemo in Patients With G.I. Cancers". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02785523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*